Products for Research Use Only
RegisterLogin

Bamlanivimab

CAT: 0931-T76849-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T76849-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2423943-37-5
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
Bamlanivimab, an Anti-Human SARS-CoV-2 monoclonal antibody (mAb), was the first of its kind to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in November 2020 for COVID-19 treatment. However, its authorization was withdrawn in April 2021 due to emerging SARS-CoV-2 variants resistant to the antibody [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
HY-P99344-01Bamlanivimab
GTR18337929-01Bamlanivimab Antibody
VK565036-01Research Grade Bamlanivimab
MBS3030540-01Bamlanivimab Biosimilar - Research Grade
21-887Bamlanivimab - Research Grade Biosimilar
GTR18780176-01(Bamlanivimab) Biosimilar Reference Antibody
GTR18698002-01Bamlanivimab Human Monoclonal Antibody
GTR18117773Bamlanivimab - Research Grade Biosimilar Antibody

Popular Products